Vizient sets roadshow for $400 million eight-year notes via Barclays

By Paul A. Harris

Portland, Ore., Jan. 29 – Vizient, Inc. plans to start a roadshow on Monday in New York for a $400 million offering of eight-year senior notes, according to a market source.

The roadshow travels to Boston on Tuesday and to the West Coast of the United States on Wednesday and Thursday.

The Rule 144A and Regulation S for life offering via bookrunner Barclays is set to price thereafter.

The notes become callable after three years at par plus 75% of the coupon and feature a three-year 40% equity clawback and a 101% poison put.

The Irving, Texas-based network of not-for-profit health care organizations plans to use the proceeds to finance the acquisition of the Spend and Clinical Resource Management and Sg2 businesses from MedAssets Inc.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.